ANGELIQ

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Malta, Mexico, Netherlands, Poland, Spain, Turkey.

Active ingredients

The drug ANGELIQ contains a combination of these active pharmaceutical ingredients (APIs):

1	Estradiol UNII CXY7B3Q98Z - ESTRADIOL HEMIHYDRATE
	Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.
	Read more about Estradiol
2	Drospirenone UNII N295J34A25 - DROSPIRENONE
	Drospirenone is a progestogen. In a therapeutic dosage, drospirenone also possesses antiandrogenic and mild antimineralocorticoid properties. It has no estrogenic, glucocorticoid and antiglucocorticoid activity. This gives drospirenone a pharmacological profile closely resembling the natural hormone progesterone.
	Read more about Drospirenone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03FA17	Drospirenone and estrogen	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03F Progestogens and estrogens in combination → G03FA Progestogens and estrogens, fixed combinations
Discover more medicines within G03FA17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	538901901112314
CA	Health Products and Food Branch	02268825
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01689021
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	26.136-01-05
EE	Ravimiamet	1165711, 1165722
ES	Centro de información online de medicamentos de la AEMPS	65583
FI	Lääkealan turvallisuus- ja kehittämiskeskus	015089
FR	Base de données publique des médicaments	67172690
HK	Department of Health Drug Office	53676
HR	Agencija za lijekove i medicinske proizvode	HR-H-410626445
IE	Health Products Regulatory Authority	12463
IL	מִשְׂרַד הַבְּרִיאוּת	4865
IT	Agenzia del Farmaco	036170013
LT	Valstybinė vaistų kontrolės tarnyba	1017736, 1017737, 1085696, 1087563
MT	Medicines Authority	MA639/01501
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	003M2005
NL	Z-Index G-Standaard, PRK	117226
PL	Rejestru Produktów Leczniczych	100137084
TR	İlaç ve Tıbbi Cihaz Kurumu	8699546097494
US	FDA, National Drug Code	50419-482, 50419-483